U.S. Markets close in 3 hrs 27 mins

Teva Pharmaceutical Industries Limited (TEVA)


NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
32.4900+1.44 (+4.64%)
As of 12:33PM EDT. Market open.
People also watch
MYLGILDNVSAMGNABT
Full screen
Previous Close31.0500
Open31.2700
Bid32.3200 x 700
Ask32.3300 x 3300
Day's Range31.2100 - 32.5000
52 Week Range27.6000 - 56.4400
Volume4,594,647
Avg. Volume7,457,859
Market Cap33.15B
Beta0.52
PE Ratio (TTM)416.54
EPS (TTM)0.08
Earnings DateN/A
Dividend & Yield1.36 (4.34%)
Ex-Dividend Date2017-06-01
1y Target Est36.83
Trade prices are not sourced from all markets
  • Glaxo's (GSK) Shingles Candidate Phase III Data Positive
    Zacks2 hours ago

    Glaxo's (GSK) Shingles Candidate Phase III Data Positive

    GlaxoSmithKline plc (GSK) announced positive top-line results from a phase III revaccination study on its shingles vaccine candidate, Shingrix, in older patients.

  • Reuters18 hours ago

    GSK wins $235 million from Teva in Coreg patent trial

    A U.S. jury has ordered Teva Pharmaceutical Industries Ltd to pay GlaxoSmithKline Plc more than $235 million for infringing a patent covering its blood pressure drug Coreg, court documents showed. A federal jury in Wilmington, Delaware on Tuesday found that Teva willfully infringed the patent in connection with its sales of a generic version of the drug with a label indicating it could be used for treating chronic heart failure. The jury rejected Teva's contention that the patent was invalid.

  • Reutersyesterday

    Israeli credit card firm Isracard names outgoing Teva CFO as chairman

    Israel's biggest credit card company Isracard on Wednesday named Eyal Desheh, the outgoing chief financial officer of Teva Pharmaceutical Industries , as its new chairman. Teva in April said Desheh would step down at end-June after nearly a decade in the job, the second top official to resign from the Israel-based company this year. Isracard is a unit of Bank Hapoalim, Israel's largest lender.